ArticleBritish journal of cancer2021

Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.

Elisabet Aliagas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.